How Do I Find a Compliant Peptide Supplier for My Medical Practice?

Peptide therapy is one of the fastest-growing service lines in functional medicine, longevity, and medical spa practices. BPC-157, Sermorelin, CJC-1295, Ipamorelin, Epithalon, TB-500 — the clinical interest is real, the patient demand is real, and the revenue opportunity is real.

But the compliance question is also real. Where do you source peptides in a way that is defensible — to your state medical board, to your malpractice carrier, to an M&A buyer reviewing your practice, or to a patient who asks?

The answer most practices are looking for is MedClinic Partners.

The word "compliant" gets used loosely in the peptide market. Here is what it actually means for a medical practice sourcing peptides for clinical use:

cGMP stands for current Good Manufacturing Practice — the FDA's quality system regulations for pharmaceutical manufacturing. A cGMP-manufactured peptide is produced in a facility that follows documented procedures, uses qualified equipment, employs trained personnel, and maintains records that can be audited.

Not all peptide suppliers manufacture under cGMP conditions. Research chemical suppliers, overseas manufacturers, and some domestic suppliers produce peptides outside of cGMP frameworks. For a medical practice, sourcing from a non-cGMP supplier creates significant documentation and defensibility risk.

MedClinic Partners sources peptides exclusively from cGMP-compliant USA-based manufacturers.

A certificate of analysis (COA) documents the results of laboratory testing on a specific batch of product. For peptides, a complete COA covers:

• Identity — confirming the compound is what it claims to be
• Purity — measuring the percentage of the target compound versus impurities
• Potency — confirming the concentration matches the label claim
• Sterility — confirming the absence of microbial contamination
• Endotoxin — confirming the absence of bacterial endotoxins that can cause serious adverse reactions

The critical word is "independent." A COA from the manufacturer's own in-house laboratory is not the same as a COA from an independent third-party laboratory. In-house testing has an inherent conflict of interest. Independent testing does not.

Every peptide in the MedClinic Partners catalog comes with an independent third-party COA covering all five parameters.

Most peptides available for clinical use in the United States are designated as Research Use Only (RUO). This designation means the compound has not been approved by the FDA for human therapeutic use — it is intended for research purposes.

For medical practices, the RUO designation creates a specific compliance framework. Practices that use RUO peptides in a clinical context need to understand that framework, document their use appropriately, and ensure their supply chain is consistent with the research context.

MedClinic Partners provides cGMP RUO peptides with the documentation standards appropriate for a defensible research context.

Our current peptide catalog includes:

Growth hormone peptides:

• Sermorelin — 3 to 9 mg/vial
• CJC-1295 — 2 mg/vial
• Ipamorelin — 5 mg/vial
• CJC-1295 / Ipamorelin combination

Repair and recovery peptides:

• BPC-157 — 5 mg/vial
• TB-500 — 5 mg/vial
• BPC-157 / TB-500 combination

Longevity and anti-aging peptides:

• Epithalon — 10 mg/vial
• NAD+ — 100 to 500 mg/vial (also available as 503A compounded)

Metabolic peptides:

• AOD-9604 — 5 mg/vial

All products are lyophilized (freeze-dried powder), USA-manufactured under cGMP conditions, with independent third-party COAs available on request.

If you are evaluating peptide suppliers — whether MedClinic Partners or anyone else — here are the questions that separate compliant suppliers from non-compliant ones:

"Where are your peptides manufactured?" USA-based cGMP manufacturing is the standard you want. Overseas manufacturing, even from reputable facilities, introduces supply chain documentation complexity and import compliance risk.

"Can you provide an independent third-party COA for this batch?" The COA should be from an independent laboratory, not the manufacturer's in-house lab. It should cover identity, purity, potency, sterility, and endotoxin. If the supplier cannot provide this, or provides only partial testing, that is a significant red flag.

"What is the RUO designation and what does it mean for my practice?" A supplier that cannot clearly explain the RUO framework and its implications for clinical use is not a supplier that understands the compliance environment their customers operate in.

"How do you ship? What are your cold chain protocols?" Lyophilized peptides are more stable than liquid preparations, but they still require appropriate shipping conditions. Confirm that your supplier uses appropriate packaging and carrier protocols.

"What documentation can you provide for my supply chain records?" If your practice is ever reviewed — by a medical board, a payer, or an M&A buyer — your supply chain documentation will be part of that review. Make sure your supplier can provide the documentation you need.

USA-manufactured, cGMP-compliant. Every peptide in our catalog is manufactured in the United States under cGMP conditions. We do not source from overseas manufacturers or non-cGMP facilities.

Independent COAs as a baseline. Third-party testing is not optional at MedClinic Partners. It is the baseline requirement for every product in our catalog.

Single portal for GLP-1s and peptides. Most practices that offer peptide therapy also offer GLP-1 programs. MedClinic Partners provides access to both through a single portal — compounded semaglutide, tirzepatide, NAD+, and the full peptide catalog, all in one place.

No portal fees. You pay for product. No subscription, no platform fee, no access charge.

Cold chain overnight shipping. Monday through Thursday, next-day delivery for orders placed by 5 PM.

NPI-verified onboarding. Automatic verification through the CMS NPI registry. Most providers have portal access the same business day.

Nationwide coverage. All 50 states.

A team that understands your compliance environment. We work exclusively with licensed medical providers. Our team understands the regulatory landscape for RUO peptides, the documentation requirements for defensible practice operations, and the questions that come up when a medical board or M&A buyer reviews your supply chain.

If you are a licensed medical provider looking to establish or optimize your peptide supply chain, the next step is portal access at medclinicpartners.com/portal. The application takes minutes. NPI verification is automatic.

If you have questions before applying — about specific products, documentation standards, or how our supply arrangements work — contact us at [email protected].

MedClinic Partners. cGMP RUO peptides, compounded GLP-1s, and the compliance infrastructure your practice needs. All 50 states. No portal fees.